The COVID-19 Nanoparticle Treatment
Classical physics allows the atom to have heat capacity at the nanoscale, the conservation of heat proceeding by a change in temperature. However, the Planck law of quantum mechanics denies the atom in nanostructures the heat capacity to conserve heat by a change in temperature. Instead, simple QED as a nanoscale heat transfer process conserves heat by creating EM radiation instead of increasing in temperature. In this regard, the creation of UV radiation from Nanoparticles (NPs) is of great interest in the disinfection of virus infections.
Since Pasteur, UV radiation is known to disinfect viruses in the air or on surrounding surfaces, but not inside human body organs. To this day, there is no known source of UV in the human body to disinfect viruses. The proposed ‘NP Treatment’ comprising intravenous injections of NPs in saline disinfect the COVID-19 virus throughout the body using UVC also disinfects any COVID-19 mutations and yet unknown viral infections that arise in the future, the Achilles heel of any COVID-19 vaccination.
With regard to COVID-19, the ‘Nanoparticle Treatment’ acts as an in vivo vaccination. Only patients diagnosed positive for COVID-19 having the virus in their body are proposed disinfected by a single injection of 80 nm lipid NPs selected to emit UVC radiation at 254 nm. Powered only by body heat, the NPs promptly inactivate at least a few live COVID-19 viruses to create the antigens necessary to elicit the immunity that inactivates the remaining COVID-19 virus in the body. Lasers used in Photodynamic Therapy are not required. Once In the blood stream, however, the NPs may enter the brain and damage neurons and DNA, but brief NP treatments of low level UVC are readily corrected by DNA repair systems. CDC testing to determine the safe acceptable NP dose levels is required. A narrated video presentation of an earlier version of ‘The Nanoparticle Treatment ‘ is available on-line at nanoQED.org [1]
References
Article Type
Opinion Article
Publication history
Received: September 14, 2021
Accepted: September 17, 2021
Published: September 21, 2021
Citation:
Prevenslik T (2021) The COVID-19 Nanoparticle Treatment. Med Case Rep Ther Stud 01(05): 32–32.
Thomas Prevenslik*
QED Radiations, Berlin, Germany
*Corresponding author
Thomas Prevenslik,
QED Radiations,
Berlin,
Germany;